Biblical Greek contains three words for word: glossa, rhema and logos. Logos is to word what agape is to love. It is the highest word for word. It is a word that means more than just a word.

In RIT’s biotechnology bachelor’s degree you’ll develop technologies for genetics, agriculture, pharmaceuticals, vaccine development, energy/ environment, forensics, and more. Hands on Experience: ...

The flyers, authorised by the neo-Nazi National Socialist Group, showcased a spoofed Liberal Party logo, with the Israeli flag in place of the Australian flag, alongside the words: "Giving the ...

Breaking down Ontario’s budget, its deficit and gloomy economic picture The searing criticism for Jivana, who had previously worked for Ford, came after the premier and his campaign manager ...

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead program and running into unresolved biology questions.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...

If you've received an innocent-sounding text from a number you don't recognize, it's not actually innocent. It's likely the start of a "wrong phone number" scam, which is increasingly being used ...

Stealth CEO Reenie McCarthy, in the company’s statement, also said that the agency has been working with the biotech to “progress its review” and recently began labeling discussions. However, the ...

According to its website, members of BioMADE include agriculture giant Cargill, defense contractor Lockheed Martin and biotech firm Amyris, among others. The Maple Grove facility is expected to put an ...

Mer­ck KGaA said Mon­day it has inked a “de­fin­i­tive agree­ment” to ac­quire Pfiz­er spin­out Spring­Works Ther­a­peu­tics for an eq­ui­ty val­ue of around $3.9 bil­lion ...

Investing.com -- HSBC downgraded several major biotech names this week, citing macroeconomic sensitivities, tariff risks, and growing pressure from regulatory changes. Most notably, the bank ...

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around $3.9 billion, expanding its portfolio of rare disease and cancer ...